Mark E Mcgovern Esperion Therapeutics, Inc. (ESPR) insider trading activity
Mark E Mcgovern is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 28,449 shares of ESPR, which is worth approximately $64,863. The most recent transaction as insider was on May 27, 2021, when has been sold 12,376 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
28.4K
0%
3M change
0%
12M change
Total Value Held
$64,863
MEM
Mark E Mcgovern
Director
Ann Arbor, MI